Answers are grounded in this paper and cite their sources.
Sleep disorders are common and have broad effects on physical and mental health. Growing evidence suggests that DNA methylation may be involved in the biological processes underlying sleep disturbances. This review summarises current evidence on DNA methylation in clinically diagnosed sleep disorders, related sleep phenotypes and exposures, and experimental sleep deprivation. Across the available studies, recurring findings involve circadian regulation, neural and synaptic function, immune and inflammatory processes, metabolic regulation and biological ageing. Some methylation changes appear to be relatively characteristic of particular disorders, including alterations involving toll-like receptor genes and vascular regulation in obstructive sleep apnoea, HLA- and chemokine-related loci in narcolepsy type 1, and glutamatergic signalling in restless legs syndrome. DNA methylation changes have been linked to symptom expression, disease severity, treatment response and recovery, suggesting possible relevance to clinical heterogeneity. However, differences in tissue source, study populations, sleep phenotyping and analytical methods limit direct comparisons across studies, and most available evidence is associative. Future studies should focus on large longitudinal cohorts, standardised study designs and multi-omics approaches to clarify underlying mechanisms, improve the reproducibility of current findings and determine the significance of DNA methylation in sleep disorders.
No takes yet. Share an insight, caveat, or question.
A et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: